Journal
JOURNAL OF MEDICAL BIOCHEMISTRY
Volume 36, Issue 4, Pages 366-374Publisher
DE GRUYTER OPEN LTD
DOI: 10.1515/jomb-2017-0009
Keywords
obesity; metabolic syndrome; inflammation; myeloperoxidase; C-reactive protein
Categories
Ask authors/readers for more resources
Background: Obesity is one of the most common modern health problems worldwide. Proinflammatory cells accumulate in the adipose tissue of the obese, and the presence of a low level chronic inflammation in obesity is associated with the emergence of a range of metabolic disorders in cluding cardiovascular disease, insulin resistance, type-2 diabetes, fatty-liver disease, and others. Neutrophils are early participants in inflammatory processes. After the appropriate stimulation, these cells release reactive oxygen and nitrogen species, which leads to degranulation and secretion of myeloperoxidase and other enzymes. Myeloper oxidase and its reactive oxidants contribute to tissue damage during inflammatory processes in the human body. Methods: The study included 175 subjects who were, in compliance with the International Diabetes Federation criteria, divided into 3 groups: normal weight subjects (N=106), subjects with abdominal obesity (N=37) and the third group consisted of subjects with the metabolic syndrome (N=32). Results: By analyzing the myeloperoxidase enzyme activity (kU/L), and the levels of high-sensitivity C-reactive protein in the blood of all subjects, we detected their significantly higher activity and levels in subjects with the metabolic syndrome, as compared to normal weight subjects (p<0.001). Conclusions: Based on our results, we can conclude that the MPO activity in the serum progressively increases with obesity and the metabolic syndrome, which indicates that this prooxidant enzyme may play a role in the pathophysiological mechanisms of the obesity and the metabolic syndrome related complications.
Authors
I am an author on this paper
Click your name to claim this paper and add it to your profile.
Reviews
Recommended
No Data Available